D. Cesarz

发表

N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).

P. Atadja, P. Lassota, K. Bair, 2003, Journal of medicinal chemistry.

Detection and structural characterization of ras oncoprotein-inhibitors complexes by electrospray mass spectrometry.

S. Liberles, J. Brown, M. Snow, 1997, Bioorganic & medicinal chemistry.

Ras oncoprotein inhibitors: the discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex.

L. Perkins, S. Liberles, J. Brown, 1997, Bioorganic & medicinal chemistry.

The Synthesis of a Novel Inhibitor of B-Raf Kinase

T. Ramsey, L. Perez, D. Batt, 2006 .

Tricyclic farnesyl protein transferase inhibitors: crystallographic and calorimetric studies of structure-activity relationships.

P. Weber, R. Doll, W. Windsor, 1999, Journal of medicinal chemistry.

Detection of p53 and MDM2 protein expression in head and neck carcinogenesis.

S. Girod, G. Krueger, U. Fischer, 1995, Anticancer research.

Synthesis of [3H], [13C215N] and [14C]Sch 66336 (Sarasar™)

D. Hesk, K. Voronin, D. Cesarz, 2000 .

Synthesis and antitumor activity of ester-modified analogues of bengamide B.

S. Zabludoff, K. Bair, P. Crews, 2001, Journal of medicinal chemistry.

Interaction of a novel GDP exchange inhibitor with the Ras protein.

J. Brown, M. Snow, C. Kissinger, 1998, Biochemistry.